The slip
PARKINSON RECEIPTno. 4945
21 Oct 2026, 04:34 UTColigodendrocytes, braak
predictionPPT2 in oligodendrocytes tracks Braak Lewy-body stage
registered54bf07c96624d842
discovery+0.36 p=0.336 n=9
replication-0.50 p=0.172 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.36, p 0.336)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT49ca09cf96a3c1480f4ce0d5…
follows 8c730cdfb5cf…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4945: PPT2 in oligodendrocytes, braak
- power
- full sample -0.22 (p 0.389, n 18), 95% CI -0.62 to +0.28. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.19 (p 0.460, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.13 (p 0.597, n 18). could be the mix.
- skeptic
- leave-one-out range -0.34 to -0.12, sign flips 0; without severely affected donors -0.22 (p 0.389, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PPT2 in oligodendrocytes.
case closed: nothing better to follow up.